StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

TDOCBearishEarningsnews
High materiality8/10

Teladoc Q2 Miss Signals Near-Term Pressure as Revenue Guidance Drops

Jul 29, 2026, 5:21 PM EDT2 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Missed revenue and reduced full-year guidance combined with a sizable after-hours drop indicate meaningful near-term downside risk.

AI summary

What happened, with direct paths to the underlying reporting

Teladoc posted Q2 revenue of $606.9 million, down 4% YoY and below consensus. Integrated Care rose modestly while BetterHelp declined, with US revenue down and cash-pay pressure mounting. The company cut full-year revenue guidance and issued a broader loss outlook, though Teladoc One launches could offer a longer-term upside, the near-term setup remains challenging.

  • Q2 revenue $606.9m, down 4% YoY, missing $615.4m consensus.
  • Integrated Care up 1% to $394.3m; BetterHelp down 12% to $212.6m.
  • US revenue down 6%; International up 7% in the quarter.
  • Teladoc One launched in the US; stock fell after-hours.
  • 3Q revenue guidance $569-609m; full-year revenue guided to $2.362-2.447b.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.